CNTNNasdaqFinance ServicesFiscal year ends December 31
Canton Strategic Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.69−0.01 (-0.29%)
Close on Oct 19, 2026
- Market cap
- $366.50M
- P/E (TTM)
- –
- Dividend yield
- –
Canton Strategic Holdings, Inc. revenue by segment
By business segment
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | YoY |
|---|---|---|---|---|---|---|---|
| Digital Asset Treasury [Member] | -$1.20M | -$35.22M | – | – | – | – | – |
| Clinical Stage Bio Technology [Member] | – | -$1.65M | – | – | -$2.55M | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Other Revenue [Member] | $1.30M | – | – | – | – | – | 87.2% | – |
| Network Validation Revenue [Member] | $191.23K | – | – | – | – | – | 12.8% | – |
By region
From the segment and revenue-disaggregation notes of Canton Strategic's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.